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Introduction: Recent studies suggest an increased risk of neurologic complications after coverage of the left subclavian
artery (LSA) during thoracic endovascular aortic repair (TEVAR). The preventative role of preoperative revascularization
of the LSA using carotid–subclavian bypass or transposition remains controversial. We assessed this increased risk and the
role of revascularization by undertaking a systematic review and meta-analysis of the literature.
Methods: In the absence of any randomized controlled trials, the Pubmed and Embase databases were searched to identify
all series reporting TEVAR without LSA coverage compared with LSA coverage with and without revascularization. The
incidence of neurologic complications, namely cerebrovascular accident (CVA) and spinal cord ischemia (SCI), were
recorded for each group. Pooled odds ratios (POR) were then calculated for postoperative CVA and SCI.
Results:Compared with patients without LSA coverage, the risk of CVA was increased both in patients with LSA coverage
alone (4.7% vs 2.7%; POR, 2.28; 95% confidence interval [CI], 1.28-4.09; P .005) and in those with LSA coverage after
revascularization (4.1% vs 2.6%; POR, 3.18; 95% CI, 1.17-8.65; P  .02). The risk of SCI was also increased in patients
requiring LSA coverage (2.8% vs 2.3%; POR, 2.39; 95% CI, 1.30-4.39; P  .005) but not for LSA coverage after
revascularization (0.8% vs 2.7%; POR, 1.69; 95% CI, 0.56-5.15; P  .35).
Conclusion. The risk of neurologic complications is increased after coverage of the LSA during TEVAR. Preemptive
revascularization offers no protection against CVA, perhaps indicating a heterogeneous etiology. Revascularization may
reduce the risk of SCI, although limited data tempers this conclusion. Improved or perhaps compulsory reporting to
registries of a minimum data set may help further assess the exact etiology of these complications and identify a higher-risk
subset of patients in whom revascularization might prove protective. ( J Vasc Surg 2009;49:1594-601.)Since the first reported case of thoracic endovascular
aortic repair (TEVAR) reported by Volodos et al,1 the
technique has expanded to be used in the treatment of a
wide variety of thoracic aortic pathologies. Indeed, evi-
dence suggests that in certain situations, the endovascular
approach has become the method of choice rather than
standard open repair.2 The cost in terms of perioperative
morbidity and mortality appears reduced.3-5 Furthermore,
the technique lends itself well to situations of major trauma,
where collateral injury supports the use of a minimally
invasive technique.6,7
The nature of the underlying pathology encountered
during TEVAR does, however, mean that the diseased
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1594segment of aorta often encroaches upon or involves the
aortic arch vessels. Recent series suggest that involvement
of zones 0 to 2 of the arch occurs in 40% of TEVAR
cases.8,9 It is well established that if covering zones 0 or 1
with an endograft is anticipated, preoperative revasculariza-
tion is a necessary adjunct to prevent significant complica-
tions. The management of patients in whom zone 2 is
involved, where left subclavian artery (LSA) coverage is
expected, has beenmore controversial. Early concerns were
predominantly for upper limb ischemia or vertebrobasilar
syndrome; however, these proved to be rare complications
that did not warrant routine preoperative revasculariza-
tion.10 More recently, several series and reviews have iden-
tified an increased risk of neurologic complications, spe-
cifically cerebrovascular accident (CVA) and spinal cord
ischemia (SCI), after coverage of the LSA.11-13
Some have suggested that preoperative revasculariza-
tion, by means of carotid–subclavian transposition or by-
pass, may be protective. There is, however, no consensus.
We undertook a systematic review with a view to a meta-
analysis of appropriate studies to help clarify whether an
increased incidence of neurologic complications is indeed
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whether preoperative LSA revascularization offers protec-
tion.
METHODS
The Pubmed and Embase databases were searched
using the dates January 1991 to March 2008. Combina-
tions of the search terms “thoracic” and “endovascular”
were used. No limits were set on the searches.
Conference proceedings from major cardiothoracic, vas-
cular, and endovascular meetings (European Association of
Cardiothoracic Surgery, Society of Vascular Surgery, Euro-
pean Society of Vascular Surgery, American Association of
Thoracic Surgery, Vascular Society of Great Britain and Ire-
land, the International Congress on Endovascular Interven-
tions, and the Western Thoracic Surgical Association) from
2000 to 2007 were searched by hand to identify additional
series. Abstracts identified by the search were scrutinized to
determine if the study was eligible for inclusion.
The reference lists of eligible series were examined to
identify any further relevant articles. In the absence of any
randomized controlled trials, all comparative studies that
reported neurologic complications (CVA and SCI) after
LSA coverage during TEVAR, with and without preoper-
ative revascularization, were identified.
All complications that occurred in the perioperative
period (30 days postoperatively, where available) were
included regardless of their proposed etiology. Only cases
where the LSA alone was covered were counted; more
complex arch revascularizations were excluded. Only pre-
operative revascularization was counted, as were any pa-
tients undergoing postoperative revascularization assessed
as non-revascularized on an intention-to-treat basis. All
etiologies leading to treatment were included.
Review articles, editorials, and case reports were ex-
cluded, as were studies with no uncovered controls. In the
case of multiple reporting of the same series, only the most
recent or comprehensive were analyzed. Few articles in-
cluded both surgical approaches to covering the LSA and
both possible neurologic complications. Therefore, all ar-
ticles comparing one or the other, or both neurologic
complications encountered for either approach to covering
the LSA (revascularized or not) with an uncovered control
were included. Each surgical approach was assessed inde-
pendently. Data were extracted from the articles or ab-
stracts into a computerized spreadsheet for analysis.
Pooled odds ratios (PORs) were calculated for LSA
coverage with and without revascularization compared
with no LSA coverage for postoperative CVA and SCI,
using a random effects model as described by Der Simonian
and Laird. The direct effect of revascularization compared
with no revascularization could not be assessed because
very few articles reported both surgical approaches. Results
are given with 95 % confidence intervals (CI). Statistical
heterogeneity was assessed by the Cochran Q test, a null
hypothesis test in which P  .05 indicates significant het-
erogeneity. Publication bias was assessed by visual inspec-
tion of funnel plots and by the Egger test. The 5% level wasconsidered significant. The statistical analysis was per-
formed using Statsdirect 2.5.7 software (Statsdirect Ltd,
Altrincham, UK).
RESULTS
The search identified 1536 abstracts. From these, 33
series provided adequate data to compare the incidence of
CVA after TEVAR, with and without LSA coverage and no
preoperative revascularization, and 13 fulfilled the criteria
for TEVAR with preoperative revascularization. With re-
spect to SCI, 36 series were included for LSA coverage
without revascularization and 13 series with revasculariza-
tion. Of note, slightly different series provided adequate
data for assessment of CVA compared with SCI.
Cerebrovascular accident. The incidence of CVA af-
ter TEVAR without coverage of the LSA was 2.7% (42 of
1575; Table I). This was significantly increased to 4.7% (19
of 402) after TEVAR with coverage of the LSA and no
preoperative revascularization (POR, 2.28; 95% CI, 1.28-
4.09; P .005; Fig 1).6,9,11,12,14-42 There was no evidence
of heterogeneity (Cochran Q, 21.69; P  .91) or bias
(Egger, 0.29; P  .22). Despite preoperative revascular-
ization, a significantly elevated risk of perioperative CVA
remained (4.1% compared with 2.6%; POR, 3.18; 95% CI,
1.17-8.65; P .02; Fig 2).9,11,12,18,24,25,36-39,42-44 Again,
no heterogeneity (Cochran Q, 10.47; P  .57) or bias
(Egger, 0.23; P  .71) was evident.
Spinal cord ischemia. A similar incidence of SCI to
CVA of 2.3% (30 of 1093; Table II) was reported after
TEVAR without coverage of the LSA. Coverage of the
LSA without preoperative revascularization significantly
increased the risk of SCI to 2.8% (POR, 2.39; 95% CI,
1.30-4.39; P  .005; Fig 3).6,9,11,12,14-24,26-42,45-48
Again, there was no evidence of heterogeneity (CochranQ,
10.74; P  .99) or bias (Egger 0.10; P  .50). However,
no significant difference was noted in the risk of SCI with
LSA coverage and preoperative revascularization compared
with no LSA coverage (0.8% vs 2.7%, respectively; POR,
1.69; 95% CI, 0.56-5.15; P  .35; Fig 4). Although
heterogeneity was not evident (CochranQ, 3.74; P .99),
there was evidence of bias (Egger 0.81; P  .01). This,
Table I. Summary of the incidence of neurologic
complications without left subclavian artery (LSA)









CVA 42/1575 (2.7) 19/402 (4.7)
Incidence of
SCI 39/1667 (2.3) 12/424 (2.8)
CVA, Cerebrovascular accident; SCI, spinal cord ischemia.
aResults include only those studies that directly compared the perioperative
incidence of either CVA, SCI, or both, with and without LSA coverage, but
without preoperative revascularization in all cases.perhaps, reflects the very small number of patients with SCI
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revascularized patients (1 of 119).
DISCUSSION
The approach to covering the LSA during TEVAR has
changed during the last decade. After an initial concern about
upper limb ischemia, the low incidence of this complication
persuaded many centers to dispose with routine preoperative
Fig 1. Forest plot illustrates the odds ratio, pooled o
cerebrovascular accident (CVA) after coverage of the le
Increased risk of CVA to the right of the vertical access.revascularization. Indeed, where troublesome limb claudica-tionormore severe ischemic symptoms such as vertebrobasilar
syndrome may develop, postoperative revascularization can
prove satisfactory management. This is generally accom-
plished by carotid–subclavian bypass or transposition.
More recently, neurologic complications such as CVA
or SCI have been identified as a much greater concern and
are far less amenable to postoperative therapy. This has led
to the practice of routine LSA coverage being re-examined
atio, and 95% confidence interval for the incidence of
clavian artery (LSA) compared with no LSA coverage.dds r
ft suband the role of preoperative revascularization reassessed.
is to
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higher incidence of neurologic complications in these pa-
tients, revascularization remains controversial.
The etiology behind CVA is unclear. The suggested
mechanisms include atheroembolization from instrumen-
tation of the aortic arch and hypoperfusion of the posterior
circulation. If the former were true, one might expect
prolonged procedure times and evidence of more athero-
matous disease in the aortic arch in those patients who
sustained a stroke. The latter is, of course, thought to be
secondary to reduced vertebral blood flow, after occlusion
Fig 2. Forest plot illustrates the odds ratio, pooled o
cerebrovascular accident (CVA) after coverage of the le
compared with no LSA coverage. Increased risk of CVA
Table II. Summary of the incidence of neurologic
complications without left subclavian artery (LSA)









CVA 29/1106 (2.6) 6/147 (4.1)
Incidence of
SCI 30/1093 (2.7) 1/119 (0.8)
CVA, Cerebrovascular accident; SCI, spinal cord ischemia.
aResults include only those studies that directly compare the perioperative
incidence of either CVA, SCI, or both, with and without LSA coverage, but
with preoperative revascularization where LSA coverage occurred.of the LSA. With this in mind, patients with a dominantleft vertebral artery, or those with an incomplete posterior
circulation, should prove more vulnerable. A dominant left
vertebral artery is, however, reported to be present in as
many as 60% of individuals, which would make revascular-
ization a serious consideration in 50%.8
Our results show that the incidence of CVA is signifi-
cantly increased after coverage of the LSA. An increase in
incidence is evident in nearly all of the series that we
assessed; however, relatively few reached statistical signifi-
cance alone owing to the small numbers included (Fig 1).
The largest single series reported is the from the European
Collaborators on Stent-Graft Techniques for Aortic Aneu-
rysm Repair (EUROSTAR) database.11 Here, an increased
incidence of CVA was reported with LSA coverage com-
pared with no LSA coverage. The most striking difference,
however, was the 0% incidence of CVA in the revascularized
group compared with almost 5% in the covered but non-
revascularized group and, indeed, 3% in the uncovered
group. These findings might support, perhaps, a role for
hypoperfusion, supported further by the lack of effect of the
degree of arch atherosclerosis. Multivariate analysis, how-
ever, identified only length of procedure and female gender
as positive risk factors for stroke. As previously mentioned,
an increased procedure length might reflect increased in-
strumentation of the aortic arch and, therefore, atheroem-
bolic risk. Contrary to this, however, studies that have
compared arch atherosclerosis with risk of stroke have
atio, and 95% confidence interval for the incidence of
clavian artery (LSA) and preoperative revascularization
the right of the vertical access.dds r
ft subfound no significant correlation.8,11
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preoperative revascularization,9,43 but most demonstra-
ted no protective effect (Fig 2). Indeed, from our meta-
analysis, the overall risk of CVA would appear to remain
significantly elevated. This in itself calls into question the
Fig 3. Forest plot illustrates the odds ratio, pooled odd
cord ischemia after coverage of the left subclavian artery (
cord ischemia is to the right of the vertical access.role of hypoperfusion, certainly in all cases of stroke. Toassess this more accurately, a review of whether each stroke
is in the anterior or posterior circulation and right or left
hemisphere might be beneficial; however, these data are
sparsely reported. The results of the studies that considered
this are summarized in Table III. Almost 50% of the CVAs
, and 95% confidence interval for the incidence of spinal
compared with no LSA coverage. Increased risk of spinals ratio
LSA)(17 of 36) were isolated in the posterior circulation. A
he ri
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rior circulation alone or the anterior circulation in conjunc-
tion with the posterior circulation. The interpretation of
these findings may be that CVA has multiple causes and,
therefore, revascularization is not exclusively protective.
In the series reported by Feezor et al,8 a more directed
approach to revascularization reduced perioperative CVA
rates from 6.4% to 2.3% and, more specifically, posterior
circulation strokes from 5.5% to 1.2%. The directed ap-
proach involved a more comprehensive preoperative assess-
ment of the cranial circulation to identify higher-risk pa-
tients such as those with a dominant left vertebral or
hypoplastic right vertebral artery, or with posterior inferior
cerebellar artery syndrome. Again, these results may sup-
Fig 4. Forest plot illustrates the odds ratio, pooled odd
cord ischemia after coverage of the left subclavian artery
LSA coverage. Increased risk of spinal cord ischemia to t
Table III. Summary of the anatomy of cerebrovascular ac
Series Circulation
(First author) Posterior Anterior
Peterson9 2 1
Marcheix17 0 1







aNo details were given in the study.port a multifactorial etiology.The anatomic basis of SCI after LSA coverage during
TEVAR is thought to be secondary to reduced anterior
spinal and costocervical arterial blood flow.13 These vessels
may prove more critical to spinal cord perfusion when
numerous intercostals vessels are covered by the stent graft.
Although the increased risk of SCI is evident from our
results, the protective role of revascularization is, again,
much less clear. This is perhaps due to the very small
number of studies reporting this complication in this co-
hort (1 SCI in 13 studies), therefore introducing bias.
Regardless, SCI is also strongly associated with the extent
of coverage of the thoracic aorta and, more specifically,
with coverage of the distal thoracic aorta near the artery of
Adamkiewicz. This is evident from studies that report an
, and 95% confidence interval for the incidence of spinal
) and preoperative revascularization compared with no












10 8 0s ratio
(LSAcidenincreased incidence of SCI associated with both an in-
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of multiple stents (suggesting greater aortic cover-
age).4,11,37,42,43 Indeed, Appoo et al43 found that in 80%
of patients with SCI, the entire thoracic aorta was covered.
Furthermore, some series have shown a correlation be-
tween concomitant or previous abdominal aortic aneurysm
repair and SCI.11,33 This finding is not universal, how-
ever.37,49 Lastly, the contribution of cerebrospinal fluid
drainage is also unclear from the data. This is due to
significant variations in its use; whether routine or selective
in high-risk patients or in limited reporting in the series we
reviewed.
The reason for a potentially increased rate of SCI after
LSA coverage cannot be identified from our results and the
series we reviewed. Because the effect of preoperative revas-
cularization is inconclusive, it remains unclear whether LSA
coverage itself results in critical spinal ischemia or whether
it is merely a surrogate marker for more extensive aortic
disease requiring more extensive coverage and, therefore,
more extensive intercostals vessel occlusion. Furthermore,
it is unclear whether revascularization is protective.
The series we have assessed clearly comprise a fairly
heterogeneous group of patients with a wide variety of
underlying aortic pathology. For example, patients who
require emergency aortic repair due to rupture or transec-
tion might be more vulnerable to hypotension and, there-
fore, neurologic injury than those who are treated in the
elective setting. Conversely, more elderly patients with
degenerative aneurysms might have more aortic arch ath-
eromatous disease and be more vulnerable to embolic
events. There is, however, no consensus that the nature of
this pathology affects the risk of neurologic complications
after TEVAR. Feezor et al8 and Buth et al,11 reporting the
EUROSTAR data, found no correlation, whereas Khoyn-
ezad et al24 found SCI was far more likely after degenerative
aneurysm repair than any other pathology. TEVAR is used
to treat a variety of chronic and acute aortic pathologies,
and our results, having assessed these as a group, may be
interpreted as applicable to all such pathologies.
Finally, it is important to acknowledge that our data are
derived from the review of nonrandomized, comparative
studies. This obviously leaves the data open to reporter
bias, over which we have no control. In the absence of any
randomized controlled trials, these are the best data avail-
able from which to draw our conclusions. However, per-
haps a more accurate interpretation of the effect of different
subgroup variables could be made by establishing a mini-
mum data set with compulsory reporting to large registries.
This would include variables such as anatomic variants in
the cranial circulation and the specific anatomy of each
CVA. With regard to SCI, we might expect more accurate
reporting of length and anatomic site of the covered tho-
racic aorta, the incidence of previous abdominal aortic
aneurysm repair, and interoperative variables, including
hypotension and the effect of prophylactic cerebrospinal
fluid drainage. This might highlight a subset of patients
who are at highest risk of neurologic complications and,
indeed, who might benefit the most from preoperativerevascularization. Alternatively, it may conclude, certainly
where SCI is considered, that other factors, which may not
be modifiable, play a far more critical role than preemptive
revascularization.
In the absence of this information, we can conclude
that the risk of neurologic complications after TEVAR is
increased when the LSA is covered. Preemptive revascular-
ization appears not protect against CVA butmay reduce the
incidence of SCI.
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